Alternatives to transvenous lead placement in a patient undergoing surgical tricuspid valve repair
Tricuspid regurgitation is a widely recognised phenomenon in patients with transvenous cardiac rhythm management (CRM) devices. If tricuspid valve repair or replacement is to be considered, what to do with the existing CRM system requires scrutiny with multidisciplinary input. We present a case of m...
Gespeichert in:
Veröffentlicht in: | Pacing and clinical electrophysiology 2023-08, Vol.46 (8), p.890-894 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 894 |
---|---|
container_issue | 8 |
container_start_page | 890 |
container_title | Pacing and clinical electrophysiology |
container_volume | 46 |
creator | Zhu, Angela Rubinstein, Matanyahu Leet, Angeline Doi, Atsuo Patel, Hitesh C |
description | Tricuspid regurgitation is a widely recognised phenomenon in patients with transvenous cardiac rhythm management (CRM) devices. If tricuspid valve repair or replacement is to be considered, what to do with the existing CRM system requires scrutiny with multidisciplinary input. We present a case of multifactorial tricuspid regurgitation in a 48‐year‐old female with giant cell myocarditis and a transvenous implantable cardioverter‐defibrillator (ICD). Key considerations in management and alternative CRM options are discussed. |
doi_str_mv | 10.1111/pace.14783 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2839251180</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2839251180</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3163-1327521e2e215d99f5256965e4cd549d68933f89a4700279aa03294767a7c60f3</originalsourceid><addsrcrecordid>eNp9kE1LwzAYgIMoOj8u_gAJeBGhmu8mxzH8goEe9Fyy9u3IyNqatJP9e1OnHjyYQ8IbnjyQB6FzSm5oWredLeGGilzzPTShUpBMU2n20YSky0xzbY7QcYwrQogiQh6iI54LRdM2QYup7yE0tncbiLhvcR9sEzfQtEPEHmyFO5_0a2h67BpscZfQcRiaCsKydc0SxyEsXWl9euvKIXauwhvrN4ADdNaFU3RQWx_h7Ps8QW_3d6-zx2z-_PA0m86zklPFM8pZLhkFBozKyphaMqmMkiDKSgpTKW04r7WxIieE5cZawpkRucptXipS8xN0tfN2oX0fIPbF2sUSvLcNpN8UTHPDJKWaJPTyD7pqh1TBj5TQSkjGRup6R5WhjTFAXXTBrW3YFpQUY_liLF98lU_wxbdyWKyh-kV_UieA7oAP52H7j6p4mc7udtJPNz-NDg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2848645220</pqid></control><display><type>article</type><title>Alternatives to transvenous lead placement in a patient undergoing surgical tricuspid valve repair</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Zhu, Angela ; Rubinstein, Matanyahu ; Leet, Angeline ; Doi, Atsuo ; Patel, Hitesh C</creator><creatorcontrib>Zhu, Angela ; Rubinstein, Matanyahu ; Leet, Angeline ; Doi, Atsuo ; Patel, Hitesh C</creatorcontrib><description>Tricuspid regurgitation is a widely recognised phenomenon in patients with transvenous cardiac rhythm management (CRM) devices. If tricuspid valve repair or replacement is to be considered, what to do with the existing CRM system requires scrutiny with multidisciplinary input. We present a case of multifactorial tricuspid regurgitation in a 48‐year‐old female with giant cell myocarditis and a transvenous implantable cardioverter‐defibrillator (ICD). Key considerations in management and alternative CRM options are discussed.</description><identifier>ISSN: 0147-8389</identifier><identifier>EISSN: 1540-8159</identifier><identifier>DOI: 10.1111/pace.14783</identifier><identifier>PMID: 37461374</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>device therapy ; epicardial ICD ; giant cell myocarditis ; Heart diseases ; ICD ; implantable cardioverter‐defibrillator ; Myocarditis ; Regurgitation ; tricuspid regurgitation ; Tricuspid valve</subject><ispartof>Pacing and clinical electrophysiology, 2023-08, Vol.46 (8), p.890-894</ispartof><rights>2023 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3163-1327521e2e215d99f5256965e4cd549d68933f89a4700279aa03294767a7c60f3</cites><orcidid>0009-0008-7817-9545</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fpace.14783$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fpace.14783$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37461374$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhu, Angela</creatorcontrib><creatorcontrib>Rubinstein, Matanyahu</creatorcontrib><creatorcontrib>Leet, Angeline</creatorcontrib><creatorcontrib>Doi, Atsuo</creatorcontrib><creatorcontrib>Patel, Hitesh C</creatorcontrib><title>Alternatives to transvenous lead placement in a patient undergoing surgical tricuspid valve repair</title><title>Pacing and clinical electrophysiology</title><addtitle>Pacing Clin Electrophysiol</addtitle><description>Tricuspid regurgitation is a widely recognised phenomenon in patients with transvenous cardiac rhythm management (CRM) devices. If tricuspid valve repair or replacement is to be considered, what to do with the existing CRM system requires scrutiny with multidisciplinary input. We present a case of multifactorial tricuspid regurgitation in a 48‐year‐old female with giant cell myocarditis and a transvenous implantable cardioverter‐defibrillator (ICD). Key considerations in management and alternative CRM options are discussed.</description><subject>device therapy</subject><subject>epicardial ICD</subject><subject>giant cell myocarditis</subject><subject>Heart diseases</subject><subject>ICD</subject><subject>implantable cardioverter‐defibrillator</subject><subject>Myocarditis</subject><subject>Regurgitation</subject><subject>tricuspid regurgitation</subject><subject>Tricuspid valve</subject><issn>0147-8389</issn><issn>1540-8159</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kE1LwzAYgIMoOj8u_gAJeBGhmu8mxzH8goEe9Fyy9u3IyNqatJP9e1OnHjyYQ8IbnjyQB6FzSm5oWredLeGGilzzPTShUpBMU2n20YSky0xzbY7QcYwrQogiQh6iI54LRdM2QYup7yE0tncbiLhvcR9sEzfQtEPEHmyFO5_0a2h67BpscZfQcRiaCsKydc0SxyEsXWl9euvKIXauwhvrN4ADdNaFU3RQWx_h7Ps8QW_3d6-zx2z-_PA0m86zklPFM8pZLhkFBozKyphaMqmMkiDKSgpTKW04r7WxIieE5cZawpkRucptXipS8xN0tfN2oX0fIPbF2sUSvLcNpN8UTHPDJKWaJPTyD7pqh1TBj5TQSkjGRup6R5WhjTFAXXTBrW3YFpQUY_liLF98lU_wxbdyWKyh-kV_UieA7oAP52H7j6p4mc7udtJPNz-NDg</recordid><startdate>202308</startdate><enddate>202308</enddate><creator>Zhu, Angela</creator><creator>Rubinstein, Matanyahu</creator><creator>Leet, Angeline</creator><creator>Doi, Atsuo</creator><creator>Patel, Hitesh C</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0009-0008-7817-9545</orcidid></search><sort><creationdate>202308</creationdate><title>Alternatives to transvenous lead placement in a patient undergoing surgical tricuspid valve repair</title><author>Zhu, Angela ; Rubinstein, Matanyahu ; Leet, Angeline ; Doi, Atsuo ; Patel, Hitesh C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3163-1327521e2e215d99f5256965e4cd549d68933f89a4700279aa03294767a7c60f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>device therapy</topic><topic>epicardial ICD</topic><topic>giant cell myocarditis</topic><topic>Heart diseases</topic><topic>ICD</topic><topic>implantable cardioverter‐defibrillator</topic><topic>Myocarditis</topic><topic>Regurgitation</topic><topic>tricuspid regurgitation</topic><topic>Tricuspid valve</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhu, Angela</creatorcontrib><creatorcontrib>Rubinstein, Matanyahu</creatorcontrib><creatorcontrib>Leet, Angeline</creatorcontrib><creatorcontrib>Doi, Atsuo</creatorcontrib><creatorcontrib>Patel, Hitesh C</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Pacing and clinical electrophysiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhu, Angela</au><au>Rubinstein, Matanyahu</au><au>Leet, Angeline</au><au>Doi, Atsuo</au><au>Patel, Hitesh C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Alternatives to transvenous lead placement in a patient undergoing surgical tricuspid valve repair</atitle><jtitle>Pacing and clinical electrophysiology</jtitle><addtitle>Pacing Clin Electrophysiol</addtitle><date>2023-08</date><risdate>2023</risdate><volume>46</volume><issue>8</issue><spage>890</spage><epage>894</epage><pages>890-894</pages><issn>0147-8389</issn><eissn>1540-8159</eissn><abstract>Tricuspid regurgitation is a widely recognised phenomenon in patients with transvenous cardiac rhythm management (CRM) devices. If tricuspid valve repair or replacement is to be considered, what to do with the existing CRM system requires scrutiny with multidisciplinary input. We present a case of multifactorial tricuspid regurgitation in a 48‐year‐old female with giant cell myocarditis and a transvenous implantable cardioverter‐defibrillator (ICD). Key considerations in management and alternative CRM options are discussed.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>37461374</pmid><doi>10.1111/pace.14783</doi><tpages>5</tpages><orcidid>https://orcid.org/0009-0008-7817-9545</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0147-8389 |
ispartof | Pacing and clinical electrophysiology, 2023-08, Vol.46 (8), p.890-894 |
issn | 0147-8389 1540-8159 |
language | eng |
recordid | cdi_proquest_miscellaneous_2839251180 |
source | Wiley Online Library Journals Frontfile Complete |
subjects | device therapy epicardial ICD giant cell myocarditis Heart diseases ICD implantable cardioverter‐defibrillator Myocarditis Regurgitation tricuspid regurgitation Tricuspid valve |
title | Alternatives to transvenous lead placement in a patient undergoing surgical tricuspid valve repair |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T14%3A29%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Alternatives%20to%20transvenous%20lead%20placement%20in%20a%20patient%20undergoing%20surgical%20tricuspid%20valve%20repair&rft.jtitle=Pacing%20and%20clinical%20electrophysiology&rft.au=Zhu,%20Angela&rft.date=2023-08&rft.volume=46&rft.issue=8&rft.spage=890&rft.epage=894&rft.pages=890-894&rft.issn=0147-8389&rft.eissn=1540-8159&rft_id=info:doi/10.1111/pace.14783&rft_dat=%3Cproquest_cross%3E2839251180%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2848645220&rft_id=info:pmid/37461374&rfr_iscdi=true |